CRYOPRESERVED MESENCHYMAL STEM CELLS IMPACT ON THE SPINAL CORD TISSUE IN RATS WITH EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS
Experemental medicine

CRYOPRESERVED MESENCHYMAL STEM CELLS IMPACT ON THE SPINAL CORD TISSUE IN RATS WITH EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS

Published 2020-12-23

Authors:

V.M. Semenova
V.I. Tsymbalyuk
L.D. Liubich
D.M. Egorova
L.P. Stayno
S.A. Verbovska
E.I. Slynko
L.D. Pichkur

Abstract:
Mesenchymal stem cells from human umbilical cord (1×106) are able to correct neurodegenerative changes in the spinal cord of rats with chronic experimental allergic encephalomyelitis under the suboccipital administration. Cells cryopreserved in solution with 3 % dimethyl sulfoxide, 15 % ethylene glycol, 10 % sucrose, 12 % trehalose, 60 % fetal calf serum, slow the build-up of pathological changes at day 35; cryopreserved in solution with 4 % dimethyl sulfoxide, 6 % trehalose, 90 % fetal calf serum, – at days 35–60; cryopreserved in solution with 10 % dimethyl sulfoxide, 90 % fetal calf serum, – have no effect. Selection of optimal cryoprotectants to save the biological properties of these cells and working out the modes and ways of their administration remains relevant.
Keywords:
mesenchymal stem cells human umbilical cord suboccipital administration spinal cord pathologically altered neurons demyelination cryoprotectants
References:
  1. Zafranskaia MM, Fedulov AS, Demydchyk UE. Effect mezenkhimalnykh stvolovykh kletok pri kletochnoy terapii rasseyannogo skleroza. Minsk: Belarus. Navuka; 2016. 213 s. [in Russian]
  2. Maslova OO, Deriabina OG, Pichkur LD, Verbovska SA, Akinola ST. Suchasni pidkhody do kriokonservuvannya klityn mezenkhimalnoho pokhodzhennya. Ukrainian Neurosurgical Journal. 2017; 1:5–10. [in Ukrainian]
  3. Nefodov AA, Mamchur VI, Tverdokhleb IV. Osobennosti ultrastruktury frontalnoy kory i gippokampa krys v usloviyah eksperimentalnogo allergicheskogo entsefalomielita. Morphologia. 2016; 10(1):54–61. [in Russian]
  4. Nefodov AA, Mamchur VI, Kharchenko YV. Modelyuvannya ta otsinka perebihu eksperimentalnoho allerhichnoho entsefalomielitu. Bulletin of problems in biology and medicine. 2014; 4(2):205–08. [in Ukrainian]
  5. Piradov MA, Suponeva NA. Autoimmunnye zabolevaniya nervnoy sistemy: sostoyaniye, problemy i perspektivy. Vestnik Rossiyskoy Akademii nayk. 2015; 70 (2): 183–87. DOI: 10.15690/vramn.v70i2.1311. [in Russian]
  6. Fedulov AS, Borisov AB, Moskovskikh YuV, Zafranskaia MM, Krivenko SI, Nizhegorodova DB et al. Autologichnaya transplantatsia mezenkhimalnykh stvolovykh kletok kak metod modifikatsii klinicheskogo techeniya rasseyannogo skleroza. Neurology and neurosurgery. Eastern Europe. 2016; 4: 516–22. [in Russian]
  7. Abumaree MH, Al Saad K, Aldlamy M, Abomaray F, Jawdat D, Al Jumah M. Human placental mesenchymal stem cells (pMSCs) modulate the immunopathogenesis process in experimental autoimmune encephalomyelitis (EAE). ECTRIMS Online Library. 2015 Oct 9, 2015;115237. Available from: https://onlinelibrary.ectrims-congress.eu/ectrims/2015/31st/115237/ mohammed. abuma-ree.human.placental. mesenchymal.stem.cells. 28pmscs29.modulate.the.html?f=m1.
  8. Al-Saqi SH, Saliem M, Quezada HC, Ekblad A, Jonasson AF, Hovatta O, Götherström C. Defined serum- and xeno-free cryopreservation of mesenchymal stem cells. Cell Tissue Banking. 2015; 16(2):181–193.
  9. Asghar W, Assal REl, Shafie H, Anchan RM, Demirci U. Preserving human cells for regenerative, reproductive, and transfusion medicine. Biotechnol J. 2014; 9(7):895–903.
  10. Chen JY, Mou XZ, Du XZ, et al. Comparative analysis of biological characteristics of adult mesenchymal stem cells with different tissue origins. Asian Pac J Trop Med. 2015; 8(9):739–46.
  11. ClinicalTrials.gov [database on the Internet]. A service of the U.S. National Institutes of Health [cited 2020 Sep 11]. Available from: http://www: clinicaltrials.gov.
  12. Jiang H, Zhang Yu, Tian K, Wang B, Han Sh. Amelioration of experimental autoimmune encephalomyelitis through transplantation of placental derived mesenchymal stem cells. Sci. Rep.2017; 7:41837. Available from: https://doi.org/10.1038/srep41837.
  13. Mantri S, Kanungo S, Mohapatra PC. Cryoprotective effect of disaccharides on cord blood stem cells with minimal use of DMSO. Ind J Hematol Blood Transfus. 2014; 31(2):206–212.
  14. Nasri F, Mohtasebi M, Hashemi E, Zarrabi M, Gholijani N, Sarvestani EK. Therapeutic Efficacy of Mesenchymal Stem Cells and Mesenchymal Stem Cells-derived Neural Progenitors in Experimental Autoimmune Encephalomyelitis. IJSC. 2018; 11:68–77. Available from: https://doi.org/10.15283/ijsc17052.
  15. Ullah I, Subbarao RB, Gyu JR. Human mesenchymal stem cells – current trends and future prospective. Biosci Rep. 2015; 35(2):e00191.
Publication:
«World of Medicine and Biology» Vol. 17 No. 75 (2021) , с. 215-220
УДК 616.832-002-056.3:591.8:612.014.43:616-092.9